Opinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash

It's difficult to get motivated about buying a stock that's plummeted or a company that seems to be out of favor with the general investment community. But if that company has bright long-term prospects, it's a great idea to stop and take a closer look. Even if a rebound doesn't happen overnight, eventually, elements like demand for that company's products or services and rising earnings should support stock performance.Meanwhile, if you buy the shares while they're down, you will have gotten in on the stock for a bargain -- and can maximize your potential gains.Today, one struggling stock in particular offers you the chance to invest for a song and possibly win big over time. This biotech giant sells what used to be one of the world's most sought-out pharma products and today has a full late-stage pipeline, signaling many possible revenue drivers ahead. In my opinion, it's time to load up on this stock after its 80% crash. Let's find out why.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool